Treatment--metformin (Q39578396)

13 September 2017

1 reference

title

Treatment--metformin (English)

1 reference

13 September 2017

1 reference

Bailey CJ

1

1 reference

13 September 2017

Nattrass M

series ordinal

2

1 reference

13 September 2017

publication date

1 May 1988

1 reference

Bailliere's clinical endocrinology and metabolism

13 September 2017

published in

1 reference

13 September 2017

volume

2

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

455-476

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

13 September 2017

1 reference

7 January 2021

Metformin revisited: its actions and indications for use.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Chronic effects of glibenclamide, chlorpropamide and metformin on plasma glucose and insulin in non-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Epidemiology of adverse drug reactions to phenformin and metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Lack of effect of glibenclamide, chlorpropamide and metformin on plasma cholesterol and HDL-cholesterol in non-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Megaloblastic anaemia due to vitamin B12 malabsorption associated with long-term metformin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin and glibenclamide: comparative risks

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Analysis of the inhibitory effect of biguanides on glucose absorption: Inhibition of active sugar transport

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Mode of action of hypoglycemic agents. IV. Control of the hypoglycemic activity of phenethylbiguanide in rats and guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Autoregulation by glucose of hepatic glucose balance: permissive effect of insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Dimethyldiguanide in the treatment of diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

The hypoglycaemic action of metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Treatment of streptozotocin-diabetic rats with metformin restores the ability of insulin to inhibit adenylate cyclase activity and demonstrates that insulin does not exert this action through the inhibitory guanine nucleotide regulatory protein Gi.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin administration in hyperlipidemic states

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Value of glucose control in preventing complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Leucocytoclastic vasculitis and pneumonitis induced by metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Rat liver glycogen-lowering activity of fed creatine--a retraction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Postreceptor effect of metformin on insulin action in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Recovery from metformin overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Effect of metformin on lipid metabolism in the rabbit aortic wall

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin action on lipid metabolism in lesions of experimental aortic atherosclerosis of rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Specific Inhibition of Gluconeogenesis by Biguanides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

1 reference

7 January 2021

Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metabolic Effects of Combined Sulphonylurea and Metformin Therapy in Maturity-Onset Diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

THE EFFECT OF METFORMIN ON WEIGHT LOSS IN OBESITY

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Pharmacokinetics of metformin after intravenous and oral administration to man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Effect of metformin on insulin binding to receptors in cultured human lymphocytes and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

5 Glucokinase of rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Direct effects of biguanides on glucose utilization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Circadian Variation of Glucose, Insulin, and Free Fatty Acids During Long-term Use of Oral Hypoglycaemic Agents in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Guanidines and biguanides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Disposition of metformin (N,N-dimethylbiguanide) in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Reduction of metformin renal tubular secretion by cimetidine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Hormone and metabolite profiles in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Diabetes and atherosclerosis ? The role of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Malabsorption of Vitamin B12 in Diabetic Patients Treated with Phenformin: A Comparison with Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin kinetics in healthy subjects and in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Metformin in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

Inhibition of Carbohydrate-Induced Hypertriglyceridemia by Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2888%2980043-0

7 January 2021

10.1016/S0950-351X(88)80043-0

Identifiers

DOI

1 reference

13 September 2017

1 reference